EUROPE MARKETS: Novartis Up, Iliad Drops: European Movers

By Carla Mozee, MarketWatch

LONDON (MarketWatch) -- Here are some of the stocks that made notable moves in European trade Monday.

HSBC PLC:Shares fell 0.9%, with investment manager Neil Woodford saying his fund sold its stake in the bank. In a blog post, Woodford said he's concerned HSBC will be issued substantial penalties stemming from an investigation into alleged rigging of the Libor interest rate and manipulation of foreign-exchange markets.

Iliad SA: Shares dropped 8.8% after the French telecommunications firm said it's in talks with several potential partners to file a new bid for control T-Mobile US Inc.

ITV PLC: The stock jumped 3.2% and moved toward its highest close in roughly 14 years, following a Telegraph report on Saturday that Liberty Global (LBTYA) is eyeing a potential takeover of the British broadcaster. Liberty Global in July bought a 6.4% stake in ITV for 481 million pounds ($799.6 million).

Novartis AG:The Swiss drug maker's shares leapt 4.6% after a clinical trial that showed Novartis' new heart treatment, LCZ696, reduced deaths in patients with chronic heart failure by 20% compared with standard therapy. Chronic heart failure affects more than 20 million people worldwide, implying a $40 billion market opportunity based on average prices for branded-cardiovascular drugs, wrote analysts at Credit Suisse on Monday.

Tesco PLC: The U.K.'s largest supermarket chain fell 2.2% after David Herro, the chief executive of Harris Associates, said the U.S. investment fund had cut its stake in Tesco to about 1%, from 3%, and is looking for a clear strategy from Tesco on how to improve business.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires